COMPANY PROFILE

Tevogen Bio

Request full access

Clinical-stage specialty immunotherapy company leveraging ExacTcellTM technology platform to harness the power of CD8+ cytotoxic T lymphocytes to develop off-the-shelf, precision T cell therapies for…

Metuchen, United StatesFounded 2020Biotech & Life Sciences

Valuation $1.20B Market cap · 2023

About Tevogen Bio

Tevogen Bio is a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T-cell therapies for the treatment of infectious diseases and cancer. The firm's proprietary ExacTcell platform harnesses the power of cytotoxic T lymphocytes (CTLs) to create scalable and rapidly producible treatments.

The company's approach focuses on developing therapeutic products that are designed to be accessible and affordable, targeting a broad range of patients. Tevogen Bio is currently advancing its pipeline of product candidates for various viral infections and cancers, leveraging its expertise in cell and gene therapy. As a publicly-traded entity, its business model is centered on the research, clinical development, and eventual commercialization of its immunotherapies.

MoreLess Source: Dealroom company data

At a glance

Status: Listed
Founded: 2020
Headquarters: Metuchen, United States
Listing: Public via SPAC 2023
Sector: Biotech & Life Sciences
Outcome tier: Unicorn$1–10B valuation tier

Knowledge graph

Founder mafias, market maps, lists and research connected to this company by Dealroom

Market maps in Biotech & Life Sciences

Market map Rare Disease Therapeutics & Technologies Landscape

Market map Digital therapeutics

Market map Psychedelic therapeutics

Unicorn lists

Biotech & Life Sciences unicorns Unicorn list Biotech & Life Sciences unicorns Unicorns in United States Unicorn list Unicorns in United States

Open roles

Track hiring at Tevogen BioOpen roles, team growth and hiring by functionBook a demo

Looking for a job? The startup jobs board lists open roles.Startups hiring now →

Tevogen Bio in the Metuchen ecosystem

Live from Dealroom

The Tevogen Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

SASemper Paratus Acquisition
POPatel family office

Talent

Book a demo to see the people

Team profiled 4 named & role-tagged

Founders /100 quality score

Key operators 2 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country

Workforce by country

2 countries with
team presence

🇺🇸 United States94.4%

🇨🇦 Canada5.6%

2 countries shown

Web traffic by country

5.2K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patents

Estimated portfolio value

$167k

3 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tevogen Bio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tevogen Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles